| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | CFO and Interim CEO
1 company
Smith Hunter C serves as a Chief Financial Officer at RYTM. Across recent SEC filings that breaks down to 0 buys and 51 sells. Those positions are worth an estimated $2.9M at current prices.
Historically, Smith Hunter C's trades have earned a below-average insider score of 38/100 across 25 rated trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -61.6%.
The biggest single holding is RYTM (~$2.9M) as Chief Financial Officer. The recent filings there lean toward selling, a net 263,504 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 4, 2025 | RYTM Rhythm Pharmaceuticals, Inc. | Chief Financial Officer | Sale+OE | 1,678 | $59.43 | $99,723.54 | -1.6% | +7.4% | +80.1% | |
| Mar 19, 2024 | RYTM Rhythm Pharmaceuticals, Inc. | Chief Financial Officer | Sell | 15,515 | $39.22 | $608,498.30 | -13.7% | +5.2% | +41.1% | |
| Feb 13, 2024 | RYTM Rhythm Pharmaceuticals, Inc. | Chief Financial Officer | Sale+OE | 1,918 | $50.80 | $97,440.80 | -2.3% | -17.8% | +17.9% | |
| Feb 1, 2024 | RYTM Rhythm Pharmaceuticals, Inc. | Chief Financial Officer | Sale+OE | 1,616 | $45.06 | $72,816.96 | -2.1% | -10.6% | +28.3% | |
| Dec 6, 2023 | RYTM Rhythm Pharmaceuticals, Inc. | Chief Financial Officer | Sale+OE | 27,026 | $38.72 | $1,046,359.66 | -30.6% | +10.8% | +55.3% | |
| Nov 24, 2023 | RYTM Rhythm Pharmaceuticals, Inc. | Chief Financial Officer | Sale+OE | 10,974 | $35.02 | $384,335.82 | -15.2% | +27.2% | +73.0% | |
| Nov 14, 2023 | RYTM Rhythm Pharmaceuticals, Inc. | Chief Financial Officer | Sale+OE | 12,000 | $30.38 | $364,573.20 | -16.3% | +58.8% | +81.9% | |
| Feb 14, 2023 | RYTM Rhythm Pharmaceuticals, Inc. | Chief Financial Officer | Sale+OE | 702 | $26.87 | $18,862.74 | -1.2% | -38.1% | +83.5% | |
| Feb 9, 2023 | RYTM Rhythm Pharmaceuticals, Inc. | Chief Financial Officer | Sale+OE | 1,398 | $27.66 | $38,668.68 | -2.4% | -37.0% | +85.0% | |
| Jul 1, 2022 | RYTM Rhythm Pharmaceuticals, Inc. | Chief Financial Officer | Sale+OE | 7,547 | $4.08 | $30,791.76 | -11.6% | +455.1% | +283.5% |